Nichol Ochsner | Vice President of Investor Relations |
Robert Finizio | Chief Executive Officer |
James D’Arecca | Chief Financial Officer |
Dawn Halkuff | Chief Commercial Officer |
Mitchell Krassan | Chief Strategy and Performance Officer |
Nick Rubino | Stifel |
Carvey Leung | Cantor Fitzgerald |
Stacy Ku | Cowen and Company |
Douglas Tsao | H.C. Wainwright |
Dana Flanders | Guggenheim |
Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Third Quarter 2020 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol, please go ahead.
Good morning, everyone.